ResMed Inc. (RMD)

190.34
11.00 6.00
NYSE
Prev Close 179.51
Open 195.80
Day Low/High 189.13 / 198.00
52 Wk Low/High 108.85 / 209.00
Volume 437.96K
Exchange NYSE
Shares Outstanding 144.91B
Market Cap 26.18B
P/E Ratio 42.31
Div & Yield N.A. (N.A)

Latest News

Upgrades, Downgrades, Initiations

Here we go folks, a sampling of this morning's upgrades, downgrades and initiations. I'll be back with some thought on these after I get another cup of my morning fuel (coffee).  Upgrades Sprint by UBS from Neutral to Buy with a $10 price target Res...

ResMed Could Rally Another 25% From Here

ResMed Could Rally Another 25% From Here

Here's how to play the stock now.

ResMed Investors Should Not Fall Asleep With Their Investments

ResMed Investors Should Not Fall Asleep With Their Investments

Let's check over the charts and indicators of ResMed.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Markets Take the Government Shutdown in Their Stride: Market Recon

Markets Take the Government Shutdown in Their Stride: Market Recon

Although equity index futures are lower, this whole thing has been taken in stride. For now.

How to Play Eight Potential Breakout Stocks

How to Play Eight Potential Breakout Stocks

A partial list of names that are showing signs of breaking out Monday.

Why CarMax and Garmin Could Be Prime Candidates for a Short Squeeze

Why CarMax and Garmin Could Be Prime Candidates for a Short Squeeze

Short-sellers are feeling the pressure this year, but you don't have to if you take a look at these four stock that could face short squeezes.

Resmed downgraded at Jefferies

Resmed downgraded at Piper

Are ResMed Shares About to Awaken?

Are ResMed Shares About to Awaken?

Shares of the maker of sleep-apnea devices are poised to rise and shine.

ResMed downgraded at Barclays

Market Wrap: Retail Takes Its Toll

Market Wrap: Retail Takes Its Toll

April report doesn't impress as averages have little to show.

Resmed upgraded at Needham

Resmed upgraded at William Blair

Resmed downgraded at UBS

Screening Major Institutions

Screening Major Institutions

Use stock lists as a source for trading ideas to pursue.

Earnings Results Could Wake ResMed Up

Earnings Results Could Wake ResMed Up

A positive report could help this maker of sleep-disorder products break out of its current consolidation.

Three Speculative Earnings Plays

Three Speculative Earnings Plays

These stocks have high short interest and could see some covering. 

Resmed upgraded at Deutsche

On Sleeping Like a Baby

On Sleeping Like a Baby

This name, which makes sleeping-disorder treatements, is a solid investment that should allow for some shut-eye.